Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-020-03579-5
Abstract: To evaluate the efficacy of a second course of fractionated stereotactic radiotherapy (re-SRT) and temozolomide (TMZ) as salvage treatment option in patients with aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs). Twenty-one patients with recurrent… read more here.
Keywords: stereotactic reirradiation; aggressive pituitary; pituitary carcinomas; year ... See more keywords
Aggressive pituitary tumours and pituitary carcinomas
Sign Up to like & getrecommendations! Published in 2021 at "Nature Reviews Endocrinology"
DOI: 10.1038/s41574-021-00550-w
Abstract: Although usually benign, anterior pituitary tumours occasionally exhibit aggressive behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional treatments and multiple recurrences. In very rare cases, they metastasize and are termed pituitary carcinomas.… read more here.
Keywords: pituitary tumours; aggressive pituitary; pituitary carcinomas; biology ... See more keywords
Pituitary carcinomas: Rare and challenging
Sign Up to like & getrecommendations! Published in 2019 at "Surgical Neurology International"
DOI: 10.25259/sni_112_2019
Abstract: Background: Pituitary carcinomas (PCs) are defined as adenohypophyseal tumors with metastatic activity within and outside the boundaries of the central nervous system (CNS). The condition is rare and therefore seldom reported; most lesions are hormone… read more here.
Keywords: pituitary carcinomas; rare challenging; case; carcinomas rare ... See more keywords